Boston Scientific Corporation recalls Capio CL; Model #M0068311350. Indicated for the placement of suture in a variety of Transvaginal procedures.
- Recall date
- February 12, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1618-2018
- FDA classification
- Class II
- Brand / firm
- Boston Scientific Corporation
- Sold / distributed
- Worldwide Distribution -- US, Brazil, Guatemala, Ecuador, Malaysia, Czech Republic, United Kingdom, Argentina, Honduras, Peru, Singapore, Denmark, Iceland, Chile, Nicaragua, Venezuela, Japan, Egypt, Israel, Canada, Panama, Taiwan, United Arab Emirates, Finland, Ireland, Mexico, Dominican Republic,…
Why it was recalled
Potential for Capio sutures to break and /or detach.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Capio CL; Model #M0068311350. Indicated for the placement of suture in a variety of Transvaginal procedures.
Get recall alerts
Free email alert whenever Boston Scientific Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Boston Scientific Corporation